Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Tempest Therapeutics, Inc. (TPST)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
14.68+0.10 (+0.69%)
At close: 4:00PM EDT
14.68 0.00 (0.00%)
After hours: 04:00PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 10/12/2021
Current
6/30/2021
Market Cap (intraday) 5
101.89M74.30M
Enterprise Value 3
52.55M74.30M
Trailing P/E
N/AN/A
Forward P/E 1
N/AN/A
PEG Ratio (5 yr expected) 1
N/AN/A
Price/Sales (ttm)
N/AN/A
Price/Book (mrq)
2.12N/A
Enterprise Value/Revenue 3
N/AN/A
Enterprise Value/EBITDA 7
-2.77-10.96

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-43.75%
S&P500 52-Week Change 330.48%
52 Week High 341.55
52 Week Low 310.39
50-Day Moving Average 314.76
200-Day Moving Average 316.02

Share Statistics

Avg Vol (3 month) 3135.04k
Avg Vol (10 day) 39.63k
Shares Outstanding 56.7M
Implied Shares Outstanding 6N/A
Float 86.05M
% Held by Insiders 11.30%
% Held by Institutions 127.39%
Shares Short (Sep 29, 2021) 481.99k
Short Ratio (Sep 29, 2021) 41.63
Short % of Float (Sep 29, 2021) 4N/A
Short % of Shares Outstanding (Sep 29, 2021) 41.22%
Shares Short (prior month Aug 30, 2021) 442.13k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 09, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Jun 27, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -21.34M
Net Income Avi to Common (ttm)-22.16M
Diluted EPS (ttm)-20.04
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)68.41M
Total Cash Per Share (mrq)10.22
Total Debt (mrq)19.07M
Total Debt/Equity (mrq)39.64
Current Ratio (mrq)7.20
Book Value Per Share (mrq)7.26

Cash Flow Statement

Operating Cash Flow (ttm)-15.08M
Levered Free Cash Flow (ttm)N/A
Advertisement
Advertisement